about
Enteral glutamine supplementation in critically ill patients: a systematic review and meta-analysisTiming of (supplemental) parenteral nutrition in critically ill patients: a systematic reviewEarly enteral nutrition in critically ill patients: ESICM clinical practice guidelines.Nutrition in the critically ill patient.Glutamine supplementation in the critically ill: friend or foe?Should we stop prescribing metoclopramide as a prokinetic drug in critically ill patients?Nurses' worry or concern and early recognition of deteriorating patients on general wards in acute care hospitals: a systematic reviewNoninvasive and invasive positive pressure ventilation for acute respiratory failure in critically ill patients: a comparative cohort studyDose Reduction of Caspofungin in Intensive Care Unit Patients with Child Pugh B Will Result in Suboptimal Exposure.How is intensive care reimbursed? A review of eight European countries.Relevance of non-nutritional calories in mechanically ventilated critically ill patients.Glutamine and antioxidants: status of their use in critical illness.Metabolic and nutritional support of critically ill patients: consensus and controversies.Enteral versus parenteral nutrition in critically ill patients: an updated systematic review and meta-analysis of randomized controlled trialsAntioxidant Vitamins and Trace Elements in Critical Illness.Diagnostic accuracy of novel serological biomarkers to detect acute mesenteric ischemia: a systematic review and meta-analysisPre-post evaluation of effects of a titanium dioxide coating on environmental contamination of an intensive care unit: the TITANIC study.Should We Increase Protein Delivery During Critical Illness?Chlorhexidine bathing and infections in critically ill patients.Glutamine, fish oil and antioxidants in critical illness: MetaPlus trial post hoc safety analysisHydrolysed protein enteral nutrition is not superior to polymeric whole protein feeding with regard to gastrointestinal feeding tolerance and feeding adequacy.Do we need new prokinetics to reduce enteral feeding intolerance during critical illness?Full or hypocaloric nutritional support for the critically ill patient: is less really more?The golden hour of antibiotic administration in severe sepsis: avoid a false start striving for gold*.No significant reduction in antibiotic treatment using a procalcitonin algorithm with low cutoff value in the intensive care unit?Nutrition barriers in abdominal aortic surgery: a multimodal approach for gastrointestinal dysfunction.Capturing early signs of deterioration: the dutch-early-nurse-worry-indicator-score and its value in the Rapid Response System.Nutritional assessment of critically ill patients: validation of the modified NUTRIC score.Nutrition in the ICU: new trends versus old-fashioned standard enteral feeding?Nurses' 'worry' as predictor of deteriorating surgical ward patients: A prospective cohort study of the Dutch-Early-Nurse-Worry-Indicator-Score.Is Less Really More with Respect to Permissive Feeding in Critical Illness?Is refeeding syndrome relevant for critically ill patients?Hypothermia or normothermia after cardiac arrest? Do not throw the baby out with the bath water?Impact of caloric intake in critically ill patients with, and without, refeeding syndrome: A retrospective study.Switching From Intermittent to Continuous Infusion of Vancomycin in Critically Ill Patients: Toward a More Robust Exposure.Effects of implementation of a computerized nutritional protocol in mechanically ventilated critically ill patients: A single-centre before and after study.Design and prospective validation of a dosing instrument for continuous infusion of vancomycin: a within-population approach.Guideline bundles adherence and mortality in severe sepsis and septic shock.In response to "Supplemental protein and energy likely account for multi-ingredient supplementation in mitigating morbidity and mortality in compromised elderly malnourished patients".Phlebitis as a consequence of peripheral intravenous administration of cisatracurium besylate in critically ill patients.
P50
Q26797452-49BF0541-7E6A-447D-8A38-ED7E2772F13DQ26865251-D49FD138-CE39-453A-B559-79A1D9DCACC6Q30238512-FA176E81-9C19-4F38-8B3B-F342111DE14AQ30238641-2443DDA2-53C2-4EDC-9CB8-0FFC56966FB5Q33752877-9DAFBE4A-FF51-4F7B-92F6-DC116F5CEC3FQ35091163-4BB6F5A5-5F95-4FAF-BCE2-1DAAAF8F5156Q35635466-747F9A47-764A-4F46-8C80-C6E0B5572F1EQ36829852-97CAE8C5-4B4D-4CD4-8659-EB8B114606D1Q36924037-013A1A69-C17C-4C84-9AEA-2AA7DADFC804Q37350140-DAFAD870-FD2F-4164-9DE7-17012049D3E0Q37496972-2EE22F69-9466-4E0C-A6FC-FF76FD66DF0FQ38319200-63707488-CEAE-46F1-B5BC-13CFFF95EC24Q38426589-1F69D6D9-5BA6-4A2D-88B0-E18CD2222019Q38821035-DCB96590-85CD-4AAB-B58C-0336E66F469FQ38867571-F61B6967-5863-47AB-BA94-04A871F75B29Q39288481-47795B37-1AFE-426A-9277-FE7703E8A246Q40198150-BE29EA2F-E71E-44B2-AEFA-B89FA97FAC62Q40807702-EE4D8315-F8D7-429B-B897-724A5325DE4DQ41238870-B0D079BA-CE0E-45C1-A43E-C3841DD9F822Q42353607-FD7A4D28-133B-4498-A9B7-8577462D9AFFQ42354268-6C6F0E47-7E38-4CC9-98DE-7D2020903680Q42391426-9B6235B4-8112-4479-854F-95CE971AE135Q42410999-AD9AB693-5FD6-42BE-9EB7-B14E2C241863Q43436432-FD030AA9-EBE2-4ADC-8BB9-C397A044B8C6Q43499666-52E1BA26-6F60-468D-B4C2-59CA8AC10D6EQ46751631-B209BE3B-0C45-43E9-9590-5E41BCDA325AQ47370999-AEE2FF65-5F81-4922-9607-3B1648312E10Q47426100-DFF97C19-BDE0-42CA-8807-C69127DEAB13Q47723308-C66AC8A3-191B-401D-9ECF-EBF4C98A9AFBQ47788518-FA6416D7-4C51-4229-B827-EBE9F5AD064AQ48180092-7653E39F-C839-45AF-B236-16C58C76C03EQ48534111-CFA79D65-C741-43FF-8678-672D6E74BA34Q49050055-B5A0E7BB-2A34-4143-87E6-F4F532F38E9FQ50491073-4BB22468-9E63-4306-B36C-232373CD38B4Q50874483-AD135020-E16A-4FB9-98A9-E92BACCD9CDCQ50988367-C682EFC7-08AB-46F2-AE31-7A9597AB2F92Q51047130-33097570-A1A6-4FD0-8CA3-561B17E26302Q51099528-7B0F9A95-FE46-4E07-B6E6-412A45D2ACDEQ51572202-856A2871-679C-4372-A3ED-DFB2B9D2A389Q51784598-22A66CE8-8363-45A2-9C48-E23ED57B4481
P50
description
investigador
@es
researcher
@en
wetenschapper
@nl
name
Arthur R H van Zanten
@en
Arthur R H van Zanten
@nl
type
label
Arthur R H van Zanten
@en
Arthur R H van Zanten
@nl
prefLabel
Arthur R H van Zanten
@en
Arthur R H van Zanten
@nl
P31
P496
0000-0001-6276-7192